Global Point-of-Care or Rapid Testing Market Research Report 2023

Report ID: 1879142 | Published Date: Jan 2025 | No. of Page: 118 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Point-of-Care or Rapid Testing Market Overview
    1.1 Product Overview and Scope of Point-of-Care or Rapid Testing
    1.2 Point-of-Care or Rapid Testing Segment by Type
        1.2.1 Global Point-of-Care or Rapid Testing Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Blood Glucose Testing
        1.2.3 Infectious Diseases Testing
        1.2.4 Cardiac Markers Testing
        1.2.5 Coagulation Testing
        1.2.6 Pregnancy and Fertility Testing
        1.2.7 Blood Gas/Electrolytes Testing
        1.2.8 Urinalysis Testing
        1.2.9 Others
    1.3 Point-of-Care or Rapid Testing Segment by Application
        1.3.1 Global Point-of-Care or Rapid Testing Sales Comparison by Application: (2022-2028)
        1.3.2 Clinics
        1.3.3 Hospitals
        1.3.4 Laboratory
        1.3.5 Others
    1.4 Global Point-of-Care or Rapid Testing Market Size Estimates and Forecasts
        1.4.1 Global Point-of-Care or Rapid Testing Revenue 2017-2028
        1.4.2 Global Point-of-Care or Rapid Testing Sales 2017-2028
        1.4.3 Point-of-Care or Rapid Testing Market Size by Region: 2017 Versus 2021 Versus 2028
2 Point-of-Care or Rapid Testing Market Competition by Manufacturers
    2.1 Global Point-of-Care or Rapid Testing Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Point-of-Care or Rapid Testing Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Point-of-Care or Rapid Testing Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Point-of-Care or Rapid Testing Manufacturing Sites, Area Served, Product Type
    2.5 Point-of-Care or Rapid Testing Market Competitive Situation and Trends
        2.5.1 Point-of-Care or Rapid Testing Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Point-of-Care or Rapid Testing Players Market Share by Revenue
        2.5.3 Global Point-of-Care or Rapid Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Point-of-Care or Rapid Testing Retrospective Market Scenario by Region
    3.1 Global Point-of-Care or Rapid Testing Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Point-of-Care or Rapid Testing Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Point-of-Care or Rapid Testing Market Facts & Figures by Country
        3.3.1 North America Point-of-Care or Rapid Testing Sales by Country
        3.3.2 North America Point-of-Care or Rapid Testing Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Point-of-Care or Rapid Testing Market Facts & Figures by Country
        3.4.1 Europe Point-of-Care or Rapid Testing Sales by Country
        3.4.2 Europe Point-of-Care or Rapid Testing Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Point-of-Care or Rapid Testing Market Facts & Figures by Region
        3.5.1 Asia Pacific Point-of-Care or Rapid Testing Sales by Region
        3.5.2 Asia Pacific Point-of-Care or Rapid Testing Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Point-of-Care or Rapid Testing Market Facts & Figures by Country
        3.6.1 Latin America Point-of-Care or Rapid Testing Sales by Country
        3.6.2 Latin America Point-of-Care or Rapid Testing Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Point-of-Care or Rapid Testing Market Facts & Figures by Country
        3.7.1 Middle East and Africa Point-of-Care or Rapid Testing Sales by Country
        3.7.2 Middle East and Africa Point-of-Care or Rapid Testing Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 U.A.E
4 Global Point-of-Care or Rapid Testing Historic Market Analysis by Type
    4.1 Global Point-of-Care or Rapid Testing Sales Market Share by Type (2017-2022)
    4.2 Global Point-of-Care or Rapid Testing Revenue Market Share by Type (2017-2022)
    4.3 Global Point-of-Care or Rapid Testing Price by Type (2017-2022)
5 Global Point-of-Care or Rapid Testing Historic Market Analysis by Application
    5.1 Global Point-of-Care or Rapid Testing Sales Market Share by Application (2017-2022)
    5.2 Global Point-of-Care or Rapid Testing Revenue Market Share by Application (2017-2022)
    5.3 Global Point-of-Care or Rapid Testing Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Roche
        6.1.1 Roche Corporation Information
        6.1.2 Roche Description and Business Overview
        6.1.3 Roche Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Roche Point-of-Care or Rapid Testing Product Portfolio
        6.1.5 Roche Recent Developments/Updates
    6.2 Abbott
        6.2.1 Abbott Corporation Information
        6.2.2 Abbott Description and Business Overview
        6.2.3 Abbott Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Abbott Point-of-Care or Rapid Testing Product Portfolio
        6.2.5 Abbott Recent Developments/Updates
    6.3 Johnson & Johnson
        6.3.1 Johnson & Johnson Corporation Information
        6.3.2 Johnson & Johnson Description and Business Overview
        6.3.3 Johnson & Johnson Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Johnson & Johnson Point-of-Care or Rapid Testing Product Portfolio
        6.3.5 Johnson & Johnson Recent Developments/Updates
    6.4 Siemens Healthcare
        6.4.1 Siemens Healthcare Corporation Information
        6.4.2 Siemens Healthcare Description and Business Overview
        6.4.3 Siemens Healthcare Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Siemens Healthcare Point-of-Care or Rapid Testing Product Portfolio
        6.4.5 Siemens Healthcare Recent Developments/Updates
    6.5 Danaher
        6.5.1 Danaher Corporation Information
        6.5.2 Danaher Description and Business Overview
        6.5.3 Danaher Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 Danaher Point-of-Care or Rapid Testing Product Portfolio
        6.5.5 Danaher Recent Developments/Updates
    6.6 Ascensia
        6.6.1 Ascensia Corporation Information
        6.6.2 Ascensia Description and Business Overview
        6.6.3 Ascensia Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 Ascensia Point-of-Care or Rapid Testing Product Portfolio
        6.6.5 Ascensia Recent Developments/Updates
    6.7 Bio-Rad Laboratories
        6.6.1 Bio-Rad Laboratories Corporation Information
        6.6.2 Bio-Rad Laboratories Description and Business Overview
        6.6.3 Bio-Rad Laboratories Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Bio-Rad Laboratories Point-of-Care or Rapid Testing Product Portfolio
        6.7.5 Bio-Rad Laboratories Recent Developments/Updates
    6.8 BioMerieux
        6.8.1 BioMerieux Corporation Information
        6.8.2 BioMerieux Description and Business Overview
        6.8.3 BioMerieux Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 BioMerieux Point-of-Care or Rapid Testing Product Portfolio
        6.8.5 BioMerieux Recent Developments/Updates
    6.9 ARKRAY
        6.9.1 ARKRAY Corporation Information
        6.9.2 ARKRAY Description and Business Overview
        6.9.3 ARKRAY Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2017-2022)
        6.9.4 ARKRAY Point-of-Care or Rapid Testing Product Portfolio
        6.9.5 ARKRAY Recent Developments/Updates
    6.10 Nova Biomedical
        6.10.1 Nova Biomedical Corporation Information
        6.10.2 Nova Biomedical Description and Business Overview
        6.10.3 Nova Biomedical Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2017-2022)
        6.10.4 Nova Biomedical Point-of-Care or Rapid Testing Product Portfolio
        6.10.5 Nova Biomedical Recent Developments/Updates
    6.11 Trividia Health
        6.11.1 Trividia Health Corporation Information
        6.11.2 Trividia Health Point-of-Care or Rapid Testing Description and Business Overview
        6.11.3 Trividia Health Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2017-2022)
        6.11.4 Trividia Health Point-of-Care or Rapid Testing Product Portfolio
        6.11.5 Trividia Health Recent Developments/Updates
    6.12 Quidel
        6.12.1 Quidel Corporation Information
        6.12.2 Quidel Point-of-Care or Rapid Testing Description and Business Overview
        6.12.3 Quidel Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2017-2022)
        6.12.4 Quidel Point-of-Care or Rapid Testing Product Portfolio
        6.12.5 Quidel Recent Developments/Updates
    6.13 Accriva
        6.13.1 Accriva Corporation Information
        6.13.2 Accriva Point-of-Care or Rapid Testing Description and Business Overview
        6.13.3 Accriva Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2017-2022)
        6.13.4 Accriva Point-of-Care or Rapid Testing Product Portfolio
        6.13.5 Accriva Recent Developments/Updates
    6.14 OraSure Technologies
        6.14.1 OraSure Technologies Corporation Information
        6.14.2 OraSure Technologies Point-of-Care or Rapid Testing Description and Business Overview
        6.14.3 OraSure Technologies Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2017-2022)
        6.14.4 OraSure Technologies Point-of-Care or Rapid Testing Product Portfolio
        6.14.5 OraSure Technologies Recent Developments/Updates
    6.15 Helena Laboratories
        6.15.1 Helena Laboratories Corporation Information
        6.15.2 Helena Laboratories Point-of-Care or Rapid Testing Description and Business Overview
        6.15.3 Helena Laboratories Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2017-2022)
        6.15.4 Helena Laboratories Point-of-Care or Rapid Testing Product Portfolio
        6.15.5 Helena Laboratories Recent Developments/Updates
    6.16 A. Menarini Diagnostics
        6.16.1 A. Menarini Diagnostics Corporation Information
        6.16.2 A. Menarini Diagnostics Point-of-Care or Rapid Testing Description and Business Overview
        6.16.3 A. Menarini Diagnostics Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2017-2022)
        6.16.4 A. Menarini Diagnostics Point-of-Care or Rapid Testing Product Portfolio
        6.16.5 A. Menarini Diagnostics Recent Developments/Updates
    6.17 Abaxis (Zoetis)
        6.17.1 Abaxis (Zoetis) Corporation Information
        6.17.2 Abaxis (Zoetis) Point-of-Care or Rapid Testing Description and Business Overview
        6.17.3 Abaxis (Zoetis) Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2017-2022)
        6.17.4 Abaxis (Zoetis) Point-of-Care or Rapid Testing Product Portfolio
        6.17.5 Abaxis (Zoetis) Recent Developments/Updates
    6.18 Ortho Clinical Diagnostics
        6.18.1 Ortho Clinical Diagnostics Corporation Information
        6.18.2 Ortho Clinical Diagnostics Point-of-Care or Rapid Testing Description and Business Overview
        6.18.3 Ortho Clinical Diagnostics Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2017-2022)
        6.18.4 Ortho Clinical Diagnostics Point-of-Care or Rapid Testing Product Portfolio
        6.18.5 Ortho Clinical Diagnostics Recent Developments/Updates
    6.19 Phamatech
        6.19.1 Phamatech Corporation Information
        6.19.2 Phamatech Point-of-Care or Rapid Testing Description and Business Overview
        6.19.3 Phamatech Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2017-2022)
        6.19.4 Phamatech Point-of-Care or Rapid Testing Product Portfolio
        6.19.5 Phamatech Recent Developments/Updates
    6.20 Chembio Diagnostics
        6.20.1 Chembio Diagnostics Corporation Information
        6.20.2 Chembio Diagnostics Point-of-Care or Rapid Testing Description and Business Overview
        6.20.3 Chembio Diagnostics Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2017-2022)
        6.20.4 Chembio Diagnostics Point-of-Care or Rapid Testing Product Portfolio
        6.20.5 Chembio Diagnostics Recent Developments/Updates
    6.21 Sinocare
        6.21.1 Sinocare Corporation Information
        6.21.2 Sinocare Point-of-Care or Rapid Testing Description and Business Overview
        6.21.3 Sinocare Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2017-2022)
        6.21.4 Sinocare Point-of-Care or Rapid Testing Product Portfolio
        6.21.5 Sinocare Recent Developments/Updates
    6.22 Wondfo
        6.22.1 Wondfo Corporation Information
        6.22.2 Wondfo Point-of-Care or Rapid Testing Description and Business Overview
        6.22.3 Wondfo Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2017-2022)
        6.22.4 Wondfo Point-of-Care or Rapid Testing Product Portfolio
        6.22.5 Wondfo Recent Developments/Updates
    6.23 Yuwell
        6.23.1 Yuwell Corporation Information
        6.23.2 Yuwell Point-of-Care or Rapid Testing Description and Business Overview
        6.23.3 Yuwell Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2017-2022)
        6.23.4 Yuwell Point-of-Care or Rapid Testing Product Portfolio
        6.23.5 Yuwell Recent Developments/Updates
    6.24 Runbio
        6.24.1 Runbio Corporation Information
        6.24.2 Runbio Point-of-Care or Rapid Testing Description and Business Overview
        6.24.3 Runbio Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2017-2022)
        6.24.4 Runbio Point-of-Care or Rapid Testing Product Portfolio
        6.24.5 Runbio Recent Developments/Updates
    6.25 KHB
        6.25.1 KHB Corporation Information
        6.25.2 KHB Point-of-Care or Rapid Testing Description and Business Overview
        6.25.3 KHB Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2017-2022)
        6.25.4 KHB Point-of-Care or Rapid Testing Product Portfolio
        6.25.5 KHB Recent Developments/Updates
    6.26 Wuhan EasyDiagnosis Biomedicine
        6.26.1 Wuhan EasyDiagnosis Biomedicine Corporation Information
        6.26.2 Wuhan EasyDiagnosis Biomedicine Point-of-Care or Rapid Testing Description and Business Overview
        6.26.3 Wuhan EasyDiagnosis Biomedicine Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2017-2022)
        6.26.4 Wuhan EasyDiagnosis Biomedicine Point-of-Care or Rapid Testing Product Portfolio
        6.26.5 Wuhan EasyDiagnosis Biomedicine Recent Developments/Updates
    6.27 DAAN GENE
        6.27.1 DAAN GENE Corporation Information
        6.27.2 DAAN GENE Point-of-Care or Rapid Testing Description and Business Overview
        6.27.3 DAAN GENE Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2017-2022)
        6.27.4 DAAN GENE Point-of-Care or Rapid Testing Product Portfolio
        6.27.5 DAAN GENE Recent Developments/Updates
7 Point-of-Care or Rapid Testing Manufacturing Cost Analysis
    7.1 Point-of-Care or Rapid Testing Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Point-of-Care or Rapid Testing
    7.4 Point-of-Care or Rapid Testing Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Point-of-Care or Rapid Testing Distributors List
    8.3 Point-of-Care or Rapid Testing Customers
9 Point-of-Care or Rapid Testing Market Dynamics
    9.1 Point-of-Care or Rapid Testing Industry Trends
    9.2 Point-of-Care or Rapid Testing Market Drivers
    9.3 Point-of-Care or Rapid Testing Market Challenges
    9.4 Point-of-Care or Rapid Testing Market Restraints
10 Global Market Forecast
    10.1 Point-of-Care or Rapid Testing Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Point-of-Care or Rapid Testing by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Point-of-Care or Rapid Testing by Type (2023-2028)
    10.2 Point-of-Care or Rapid Testing Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Point-of-Care or Rapid Testing by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Point-of-Care or Rapid Testing by Application (2023-2028)
    10.3 Point-of-Care or Rapid Testing Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Point-of-Care or Rapid Testing by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Point-of-Care or Rapid Testing by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global Point-of-Care or Rapid Testing Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global Point-of-Care or Rapid Testing Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global Point-of-Care or Rapid Testing Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Point-of-Care or Rapid Testing Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Point-of-Care or Rapid Testing Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global Point-of-Care or Rapid Testing Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Point-of-Care or Rapid Testing Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Point-of-Care or Rapid Testing Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Point-of-Care or Rapid Testing Average Price (USD/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Point-of-Care or Rapid Testing Manufacturing Sites and Area Served
    Table 11. Manufacturers Point-of-Care or Rapid Testing Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Point-of-Care or Rapid Testing by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Point-of-Care or Rapid Testing as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Point-of-Care or Rapid Testing Sales by Region (2017-2022) & (K Units)
    Table 16. Global Point-of-Care or Rapid Testing Sales Market Share by Region (2017-2022)
    Table 17. Global Point-of-Care or Rapid Testing Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Point-of-Care or Rapid Testing Revenue Market Share by Region (2017-2022)
    Table 19. North America Point-of-Care or Rapid Testing Sales by Country (2017-2022) & (K Units)
    Table 20. North America Point-of-Care or Rapid Testing Sales Market Share by Country (2017-2022)
    Table 21. North America Point-of-Care or Rapid Testing Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Point-of-Care or Rapid Testing Revenue Market Share by Country (2017-2022)
    Table 23. Europe Point-of-Care or Rapid Testing Sales by Country (2017-2022) & (K Units)
    Table 24. Europe Point-of-Care or Rapid Testing Sales Market Share by Country (2017-2022)
    Table 25. Europe Point-of-Care or Rapid Testing Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Point-of-Care or Rapid Testing Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Point-of-Care or Rapid Testing Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific Point-of-Care or Rapid Testing Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Point-of-Care or Rapid Testing Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Point-of-Care or Rapid Testing Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Point-of-Care or Rapid Testing Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America Point-of-Care or Rapid Testing Sales Market Share by Country (2017-2022)
    Table 33. Latin America Point-of-Care or Rapid Testing Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Point-of-Care or Rapid Testing Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Point-of-Care or Rapid Testing Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa Point-of-Care or Rapid Testing Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Point-of-Care or Rapid Testing Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Point-of-Care or Rapid Testing Revenue Market Share by Country (2017-2022)
    Table 39. Global Point-of-Care or Rapid Testing Sales by Type (2017-2022) & (K Units)
    Table 40. Global Point-of-Care or Rapid Testing Sales Market Share by Type (2017-2022)
    Table 41. Global Point-of-Care or Rapid Testing Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Point-of-Care or Rapid Testing Revenue Share by Type (2017-2022)
    Table 43. Global Point-of-Care or Rapid Testing Price by Type (2017-2022) & (USD/Unit)
    Table 44. Global Point-of-Care or Rapid Testing Sales (K Units) by Application (2017-2022)
    Table 45. Global Point-of-Care or Rapid Testing Sales Market Share by Application (2017-2022)
    Table 46. Global Point-of-Care or Rapid Testing Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Point-of-Care or Rapid Testing Revenue Share by Application (2017-2022)
    Table 48. Global Point-of-Care or Rapid Testing Price by Application (2017-2022) & (USD/Unit)
    Table 49. Roche Corporation Information
    Table 50. Roche Description and Business Overview
    Table 51. Roche Point-of-Care or Rapid Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 52. Roche Point-of-Care or Rapid Testing Product
    Table 53. Roche Recent Developments/Updates
    Table 54. Abbott Corporation Information
    Table 55. Abbott Description and Business Overview
    Table 56. Abbott Point-of-Care or Rapid Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 57. Abbott Point-of-Care or Rapid Testing Product
    Table 58. Abbott Recent Developments/Updates
    Table 59. Johnson & Johnson Corporation Information
    Table 60. Johnson & Johnson Description and Business Overview
    Table 61. Johnson & Johnson Point-of-Care or Rapid Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 62. Johnson & Johnson Point-of-Care or Rapid Testing Product
    Table 63. Johnson & Johnson Recent Developments/Updates
    Table 64. Siemens Healthcare Corporation Information
    Table 65. Siemens Healthcare Description and Business Overview
    Table 66. Siemens Healthcare Point-of-Care or Rapid Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 67. Siemens Healthcare Point-of-Care or Rapid Testing Product
    Table 68. Siemens Healthcare Recent Developments/Updates
    Table 69. Danaher Corporation Information
    Table 70. Danaher Description and Business Overview
    Table 71. Danaher Point-of-Care or Rapid Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 72. Danaher Point-of-Care or Rapid Testing Product
    Table 73. Danaher Recent Developments/Updates
    Table 74. Ascensia Corporation Information
    Table 75. Ascensia Description and Business Overview
    Table 76. Ascensia Point-of-Care or Rapid Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 77. Ascensia Point-of-Care or Rapid Testing Product
    Table 78. Ascensia Recent Developments/Updates
    Table 79. Bio-Rad Laboratories Corporation Information
    Table 80. Bio-Rad Laboratories Description and Business Overview
    Table 81. Bio-Rad Laboratories Point-of-Care or Rapid Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 82. Bio-Rad Laboratories Point-of-Care or Rapid Testing Product
    Table 83. Bio-Rad Laboratories Recent Developments/Updates
    Table 84. BioMerieux Corporation Information
    Table 85. BioMerieux Description and Business Overview
    Table 86. BioMerieux Point-of-Care or Rapid Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 87. BioMerieux Point-of-Care or Rapid Testing Product
    Table 88. BioMerieux Recent Developments/Updates
    Table 89. ARKRAY Corporation Information
    Table 90. ARKRAY Description and Business Overview
    Table 91. ARKRAY Point-of-Care or Rapid Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 92. ARKRAY Point-of-Care or Rapid Testing Product
    Table 93. ARKRAY Recent Developments/Updates
    Table 94. Nova Biomedical Corporation Information
    Table 95. Nova Biomedical Description and Business Overview
    Table 96. Nova Biomedical Point-of-Care or Rapid Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 97. Nova Biomedical Point-of-Care or Rapid Testing Product
    Table 98. Nova Biomedical Recent Developments/Updates
    Table 99. Trividia Health Corporation Information
    Table 100. Trividia Health Description and Business Overview
    Table 101. Trividia Health Point-of-Care or Rapid Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 102. Trividia Health Point-of-Care or Rapid Testing Product
    Table 103. Trividia Health Recent Developments/Updates
    Table 104. Quidel Corporation Information
    Table 105. Quidel Description and Business Overview
    Table 106. Quidel Point-of-Care or Rapid Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 107. Quidel Point-of-Care or Rapid Testing Product
    Table 108. Quidel Recent Developments/Updates
    Table 109. Accriva Corporation Information
    Table 110. Accriva Description and Business Overview
    Table 111. Accriva Point-of-Care or Rapid Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 112. Accriva Point-of-Care or Rapid Testing Product
    Table 113. Accriva Recent Developments/Updates
    Table 114. OraSure Technologies Corporation Information
    Table 115. OraSure Technologies Description and Business Overview
    Table 116. OraSure Technologies Point-of-Care or Rapid Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 117. OraSure Technologies Point-of-Care or Rapid Testing Product
    Table 118. OraSure Technologies Recent Developments/Updates
    Table 119. Helena Laboratories Corporation Information
    Table 120. Helena Laboratories Description and Business Overview
    Table 121. Helena Laboratories Point-of-Care or Rapid Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 122. Helena Laboratories Point-of-Care or Rapid Testing Product
    Table 123. Helena Laboratories Recent Developments/Updates
    Table 124. A. Menarini Diagnostics Corporation Information
    Table 125. A. Menarini Diagnostics Description and Business Overview
    Table 126. A. Menarini Diagnostics Point-of-Care or Rapid Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 127. A. Menarini Diagnostics Point-of-Care or Rapid Testing Product
    Table 128. A. Menarini Diagnostics Recent Developments/Updates
    Table 129. Abaxis (Zoetis) Corporation Information
    Table 130. Abaxis (Zoetis) Description and Business Overview
    Table 131. Abaxis (Zoetis) Point-of-Care or Rapid Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 132. Abaxis (Zoetis) Point-of-Care or Rapid Testing Product
    Table 133. Abaxis (Zoetis) Recent Developments/Updates
    Table 134. Ortho Clinical Diagnostics Corporation Information
    Table 135. Ortho Clinical Diagnostics Description and Business Overview
    Table 136. Ortho Clinical Diagnostics Point-of-Care or Rapid Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 137. Ortho Clinical Diagnostics Point-of-Care or Rapid Testing Product
    Table 138. Ortho Clinical Diagnostics Recent Developments/Updates
    Table 139. Phamatech Corporation Information
    Table 140. Phamatech Description and Business Overview
    Table 141. Phamatech Point-of-Care or Rapid Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 142. Phamatech Point-of-Care or Rapid Testing Product
    Table 143. Phamatech Recent Developments/Updates
    Table 144. Chembio Diagnostics Corporation Information
    Table 145. Chembio Diagnostics Description and Business Overview
    Table 146. Chembio Diagnostics Point-of-Care or Rapid Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 147. Chembio Diagnostics Point-of-Care or Rapid Testing Product
    Table 148. Chembio Diagnostics Recent Developments/Updates
    Table 149. Sinocare Corporation Information
    Table 150. Sinocare Description and Business Overview
    Table 151. Sinocare Point-of-Care or Rapid Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 152. Sinocare Point-of-Care or Rapid Testing Product
    Table 153. Sinocare Recent Developments/Updates
    Table 154. Wondfo Corporation Information
    Table 155. Wondfo Description and Business Overview
    Table 156. Wondfo Point-of-Care or Rapid Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 157. Wondfo Point-of-Care or Rapid Testing Product
    Table 158. Wondfo Recent Developments/Updates
    Table 159. Yuwell Corporation Information
    Table 160. Yuwell Description and Business Overview
    Table 161. Yuwell Point-of-Care or Rapid Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 162. Yuwell Point-of-Care or Rapid Testing Product
    Table 163. Yuwell Recent Developments/Updates
    Table 164. Runbio Corporation Information
    Table 165. Runbio Description and Business Overview
    Table 166. Runbio Point-of-Care or Rapid Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 167. Runbio Point-of-Care or Rapid Testing Product
    Table 168. Runbio Recent Developments/Updates
    Table 169. KHB Corporation Information
    Table 170. KHB Description and Business Overview
    Table 171. KHB Point-of-Care or Rapid Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 172. KHB Point-of-Care or Rapid Testing Product
    Table 173. KHB Recent Developments/Updates
    Table 174. Wuhan EasyDiagnosis Biomedicine Corporation Information
    Table 175. Wuhan EasyDiagnosis Biomedicine Description and Business Overview
    Table 176. Wuhan EasyDiagnosis Biomedicine Point-of-Care or Rapid Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 177. Wuhan EasyDiagnosis Biomedicine Point-of-Care or Rapid Testing Product
    Table 178. Wuhan EasyDiagnosis Biomedicine Recent Developments/Updates
    Table 179. DAAN GENE Corporation Information
    Table 180. DAAN GENE Description and Business Overview
    Table 181. DAAN GENE Point-of-Care or Rapid Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 182. DAAN GENE Point-of-Care or Rapid Testing Product
    Table 183. DAAN GENE Recent Developments/Updates
    Table 184. Production Base and Market Concentration Rate of Raw Material
    Table 185. Key Suppliers of Raw Materials
    Table 186. Point-of-Care or Rapid Testing Distributors List
    Table 187. Point-of-Care or Rapid Testing Customers List
    Table 188. Point-of-Care or Rapid Testing Market Trends
    Table 189. Point-of-Care or Rapid Testing Market Drivers
    Table 190. Point-of-Care or Rapid Testing Market Challenges
    Table 191. Point-of-Care or Rapid Testing Market Restraints
    Table 192. Global Point-of-Care or Rapid Testing Sales Forecast by Type (2023-2028) & (K Units)
    Table 193. Global Point-of-Care or Rapid Testing Sales Market Share Forecast by Type (2023-2028)
    Table 194. Global Point-of-Care or Rapid Testing Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 195. Global Point-of-Care or Rapid Testing Revenue Market Share Forecast by Type (2023-2028)
    Table 196. Global Point-of-Care or Rapid Testing Sales Forecast by Application (2023-2028) & (K Units)
    Table 197. Global Point-of-Care or Rapid Testing Sales Market Share Forecast by Application (2023-2028)
    Table 198. Global Point-of-Care or Rapid Testing Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 199. Global Point-of-Care or Rapid Testing Revenue Market Share Forecast by Application (2023-2028)
    Table 200. Global Point-of-Care or Rapid Testing Sales Forecast by Region (2023-2028) & (K Units)
    Table 201. Global Point-of-Care or Rapid Testing Sales Market Share Forecast by Region (2023-2028)
    Table 202. Global Point-of-Care or Rapid Testing Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 203. Global Point-of-Care or Rapid Testing Revenue Market Share Forecast by Region (2023-2028)
    Table 204. Research Programs/Design for This Report
    Table 205. Key Data Information from Secondary Sources
    Table 206. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Point-of-Care or Rapid Testing
    Figure 2. Global Point-of-Care or Rapid Testing Market Share by Type in 2021 & 2028
    Figure 3. Blood Glucose Testing Product Picture
    Figure 4. Infectious Diseases Testing Product Picture
    Figure 5. Cardiac Markers Testing Product Picture
    Figure 6. Coagulation Testing Product Picture
    Figure 7. Pregnancy and Fertility Testing Product Picture
    Figure 8. Blood Gas/Electrolytes Testing Product Picture
    Figure 9. Urinalysis Testing Product Picture
    Figure 10. Others Product Picture
    Figure 11. Global Point-of-Care or Rapid Testing Market Share by Application in 2021 & 2028
    Figure 12. Clinics
    Figure 13. Hospitals
    Figure 14. Laboratory
    Figure 15. Others
    Figure 16. Global Point-of-Care or Rapid Testing Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 17. Global Point-of-Care or Rapid Testing Market Size (2017-2028) & (US$ Million)
    Figure 18. Global Point-of-Care or Rapid Testing Sales (2017-2028) & (K Units)
    Figure 19. Point-of-Care or Rapid Testing Sales Share by Manufacturers in 2021
    Figure 20. Global Point-of-Care or Rapid Testing Revenue Share by Manufacturers in 2021
    Figure 21. The Global 5 and 10 Largest Point-of-Care or Rapid Testing Players: Market Share by Revenue in 2021
    Figure 22. Point-of-Care or Rapid Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 23. Global Point-of-Care or Rapid Testing Sales Market Share by Region (2017-2022)
    Figure 24. Global Point-of-Care or Rapid Testing Sales Market Share by Region in 2021
    Figure 25. Global Point-of-Care or Rapid Testing Revenue Market Share by Region (2017-2022)
    Figure 26. Global Point-of-Care or Rapid Testing Revenue Market Share by Region in 2021
    Figure 27. U.S. Point-of-Care or Rapid Testing Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. Canada Point-of-Care or Rapid Testing Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. Germany Point-of-Care or Rapid Testing Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. France Point-of-Care or Rapid Testing Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. U.K. Point-of-Care or Rapid Testing Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. Italy Point-of-Care or Rapid Testing Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Russia Point-of-Care or Rapid Testing Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. China Point-of-Care or Rapid Testing Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Japan Point-of-Care or Rapid Testing Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. South Korea Point-of-Care or Rapid Testing Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. India Point-of-Care or Rapid Testing Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Australia Point-of-Care or Rapid Testing Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Taiwan Point-of-Care or Rapid Testing Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Indonesia Point-of-Care or Rapid Testing Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Thailand Point-of-Care or Rapid Testing Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Malaysia Point-of-Care or Rapid Testing Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Philippines Point-of-Care or Rapid Testing Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. Vietnam Point-of-Care or Rapid Testing Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 45. Mexico Point-of-Care or Rapid Testing Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 46. Brazil Point-of-Care or Rapid Testing Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 47. Argentina Point-of-Care or Rapid Testing Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 48. Turkey Point-of-Care or Rapid Testing Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 49. Saudi Arabia Point-of-Care or Rapid Testing Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 50. U.A.E Point-of-Care or Rapid Testing Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 51. Sales Market Share of Point-of-Care or Rapid Testing by Type (2017-2022)
    Figure 52. Manufacturing Cost Structure of Point-of-Care or Rapid Testing
    Figure 53. Manufacturing Process Analysis of Point-of-Care or Rapid Testing
    Figure 54. Point-of-Care or Rapid Testing Industrial Chain Analysis
    Figure 55. Channels of Distribution
    Figure 56. Distributors Profiles
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation
    Figure 59. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Roche
Abbott
Johnson & Johnson
Siemens Healthcare
Danaher
Ascensia
Bio-Rad Laboratories
BioMerieux
ARKRAY
Nova Biomedical
Trividia Health
Quidel
Accriva
OraSure Technologies
Helena Laboratories
A. Menarini Diagnostics
Abaxis (Zoetis)
Ortho Clinical Diagnostics
Phamatech
Chembio Diagnostics
Sinocare
Wondfo
Yuwell
Runbio
KHB
Wuhan EasyDiagnosis Biomedicine
DAAN GENE
Frequently Asked Questions
Point-of-Care or Rapid Testing report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Point-of-Care or Rapid Testing report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Point-of-Care or Rapid Testing report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports